Endogenex, Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study Evaluating the Metabolic Effects of pulsENDO Therapy in Adults With Type 2 Diabetes (NCT07768631) | Endogenex, Inc. | 2027-01-01 |
| Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study (NCT07197788) | Endogenex, Inc. | 2026-09-01 |
| Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry) (NCT07197775) | Endogenex, Inc. | 2026-03-11 |
| Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (NCT06267391) | Endogenex, Inc. | 2024-05-01 |
| Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes (NCT05014204) | Endogenex, Inc. | 2021-10-29 |
| Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes (NCT04725890) | Endogenex, Inc. | 2021-04-20 |
Track Endogenex, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.